10 Master Scholarship Journalism


Global Communication and International Journalism – Double Degree Master’s Program

Version7

Saint Petersburg State University (SPbU)-Freie Universität Berlin (FU)

The Master’s Program Global Communication and International Journalism is conducted by the Institute for Media and Communication Studies, FU Berlin, and the School of Journalism and Mass Communications, SPbU. It attracts graduates with a BA level or higher academic degree or a Specialist university degree in social sciences as well as humanities. The program provides students with the analytical, methodological and practical competencies necessary for understanding and researching global communication and international journalism developments.

The graduates of the double degree program are well prepared for a career in journalism as well as an academic career in media research both in universities and in the private sector. They have the necessary competencies to engage in editorial boards or management of organizations and various sectors of global mass media. They are ready to work in media consultancy, political education and intercultural communication.

Courses are taught in English; an academic degree from both universities is provided upon graduation. Students attend courses in St. Petersburg and in Berlin.

Major Aims and Topics

Students will get a double-competency qualification based on academic studies and practical training. They are to acquire accurate and deep understanding of communication theory and develop comprehensive knowledge of important research in the field of international media and communication. They must further learn to develop their own research questions in the context of existing theories and relevant research areas. Special significance is attributed to international comparative theoretical and empirical approaches that consider structural changes in media and society: following this perspective, the development of global media and communication processes is understood as crossing national borders.

Professional and independent work on an international level is one of the major goals of the program. Students analyze and develop a thorough understanding of new media technological developments and the impacts and obstacles of the digitalization of mediated communication. They critically assess the importance of innovation and globalization in mass media from political, economic, cultural, legal and ethical perspectives.

Core Areas of Research and Teaching

  • Communication Studies and Research Methods
  • Journalism Studies and Journalistic Practice
  • Media Systems in Comparative Perspectives
  • Globalization and Media
  • International Journalism Culture
  • Modern Media Management
  • Internship / Research Practice

Detailed information on the curriculum of the program is provided in the study and examination regulations (German version, pdf).

Important Information on the Course of Studies

The first and third semesters are studied at SPbU in St. Petersburg, the second semester is studied at FU in Berlin. Depending on the student’s individual choice of the MA thesis supervisor (following research interest and chosen topic), the final semester is either studied at SPbU or FU.

Degree Master of Arts (M.A.)
Duration 4 semesters
Application period for
international students
May 25 – July 10, 2014
Program start Winter semester, September 2014
Language English

Tuition Fees and Scholarships

Both universities offer up to 10 funded places for German / international students. While studying at SPbU, German students can apply for an additional DAAD scholarship. While studying at FU, Russian / international students can apply for a grant.

FU Berlin does not charge tuition fees for consecutive master’s programs. Instead, the university charges all students with “semester fees and contributions” of circa EUR 300, including public transportation costs in Berlin.

Students enrolled on the fee-paying basis pay tuition fees set by SPbU, which is fixed at the sum of 90.000 roubles per semester.

Pictures above: © Saint Petersburg State University (left), FU Berlin / CeDiS (right)

 

PhD Scholarships at King Abdullah University of Science & Technology

PhD Scholarships at King Abdullah University of Science & Technology The fellowship covers:

1. 25000 USD yearly stipend

2. Free housing with 1 bedroom for single, 2 bedrooms for married students.

3. Insurance up to 15000 USD/year

4. Round trip ticket to home countries per year for the student and dependents

. 5. Waived tuition fee (35000 USD)

6. Opportunity to collaborate in research with multinational company, top-rank universities, and have access to high-end research facilities

7. Chance to live in a very heterogeneous environment with more than 70% students and faculties coming from US, Europe, China, Japan, South Korea etc.

8. For Muslim students, our campus is located 2 hours from Makkah, and the campus provides free buses to Mekkah 2 times a week for Umrah.

11 PhD positions for applicants from the natural sciences

Available Positions

The i-Target doctoral program offers financial support for 11 PhD positions for applicants from the natural sciences for the following projects A to K.

Applications are only possible online using the following link: portal.graduatecenter-lmu.de/i-target. The application portal will be open from may May 19th through June 20th 2014. For any inquiries concerning the program or the application process, please contact the i-Target staff: itarget@med.uni-muenchen.de. Please note that applications submitted by email will not be considered.

Research Area 1: Targeted cellular therapy

  • A: Arming tumor specific T cells with CC motive receptors

    Principle investigators: PD Dr. Sebastian Kobold and Prof. Stefan Endres

    Brief description: Adoptive T cell therapy is one of the most promising approaches for the treatment of cancer. A major limitation is the infiltration or homing of the transferred T cells to the tumor site. The aim of this PhD-project will be to overexpress defined chemokine receptors on tumor-specific T cells to enhance the efficacy of adoptive T cell therapy. The methods will comprise a wide range of cellular and immunological methods and will include in vivo experiments.

    Homepage: www.klinikum.uni-muenchen.de/Abteilung-fuer-Klinische-Pharmakologie/de

  • B: Enhancing T cell therapy through activating receptors

    Principle investigators: PD Dr. Sebastian Kobold and Prof. Stefan Endres

    Brief description: Tumors mount an effective immunosuppressive milieu to prevent immune cells to efficiently recognize tumor cells and suppress their activity. The aim of this Ph. D. project will be to overexpress in-house engineered activating receptors to enhance the efficacy of adoptive T cell therapy. The methods will comprise a wide range of cellular and immunological methods and will include in vivo experiments.

    Homepage: www.klinikum.uni-muenchen.de/Abteilung-fuer-Klinische-Pharmakologie/de

  • C: Engagement of T cells through bispecific antibodies

    Principle investigators: PD Dr. Sebastian Kobold and Prof. Stefan Endres

    Brief description: Bispecific antibodies have the great advantage of specific targeting of two different antigens, allowing for both immune and tumor cell binding. The aim of this Ph. D. project will be to design and use new bispecific antibodies to enhance the efficacy of adoptive T cell therapy. The methods will comprise a wide range of cellular and immunological methods and will include in vivo experiments.

    Homepage: www.klinikum.uni-muenchen.de/Abteilung-fuer-Klinische-Pharmakologie/de

  • D: Therapeutic vaccines and immune check point blockade in leukemia

    Principle investigator: PD Dr. Marion Subklewe; Department of hematology / oncology, University Hospital of the Ludwig-Maximailians-Universität, Munich, Germany

    Brief description: We have documented the generation of superior dendritic cells (DCs) from monocytes of AML patients using a fast, TLR ligand-containing maturation cocktail. Based on our preclinical data, we have initiated a proof-of-concept trial using RNA-transfected DCs for postremission therapy in AML. Therapeutic vaccinations induced cellular immune responses may be hampered by upregulation of immune inhibitory molecules (“immune checkpoint markers”) on target cells.

    The aim of this Ph.D. project is to identify immuninhibitory pathways relevant in AML as mechanisms of immune escape and as therapeutic targets. The therapeutic potential of checkpoint inhibitors and other immunmodulatory drugs will be assessed in vitro and in collaboration also in an in vivo AML mouse model. The methods will comprise a wide range of cellular and immunological methods and will optionally include in vivo experiments.

    Homepage: www.klinikum.uni-muenchen.de/Medizinische-Klinik-und-Poliklinik-III/de/team/oberaerzte/subklewe_m

 

Research Area 2: Targeted immunomodulatory therapy

  • E: Development of innovative multispecific antibody derivatives for the specific recruitment of immune effector cells to tumor cells

    Principle investigator: Prof. Dr. rer. nat. Karl-Peter Hopfner

    Brief description: The project will involve a combination of protein engineering, protein biochemistry and functional studies (cell culture, cell lysis assays, FACS). In collaboration with other iTarget members, the final goal of the PhD thesis is to test the efficacy in mouse models.

    Homepage: www.hopfner.genzentrum.lmu.de

  • F: Identifying novel immunological epitopes for immunotherapy of acute myeloid leukemia.

    Principle investigators: Prof. Dr. Christoph Klein, Dr. von Hauner Children’s Hospital, Ludwig-Maximilians-University, Munich, Germany.

    Brief description: In this Phd project we plan to develop a research pipeline to discover novel therapeutic targets for AML by deciphering key factors controlling myeloid cell differentiation. Thus we wish to study the potential role of novel targets in murine leukemia cells as well as the identification of novel pathways via genome-wide analysis of rare children with monogenetic diseases. We plan to design monoclonal antibodies and chimeric T-cell receptors recognizing specific membrane-bound proteins and anticipate that immune-targeting will selectively eliminate myeloid cells. Immune-effectors will be systematically assessed in vitro and in vivo for their capacity to recognize and kill myeloid leukemia cells. The methods will comprise a wide range of cellular, immunological and biochemical methods as well as in vivo experiments.

    Homepage: www.klein.genzentrum.lmu.de

  • G: Induction of anti-leukemic T-cell responses by bystander killing of CD33+ myeloid-derived suppressor cells via a CD33/CD3-bispecific BiTE® antibody construct

    Principle investigators: Prof. Dr. Andreas Mackensen and PD Dr. Dimitrios Mougiakakos, Department of Hematology and Oncology, University Hospital, Friedrich-Alexander-University, Erlangen, Germany

    Brief description: In recent years myeloid derived suppressor cells (MDSCs) have emerged as a key cell subset that promotes tumor immune escape. Strategies to overcome MDSC-mediated immune suppression hold promise to improve efficacy of modern immunotherapies. The aim of this PhD project is to (1) characterize MDSCs in patients with acute myeloid leukemia (AML) in order to (2) target them with a novel so-called CD33/CD3 bi-specific antibody (AMG330) showing a high anti-leukemic activity. In doing so we hope elicit two critical hits against AML. The methods utilized in this translational project will comprise a broad variety of cellular, molecular, and immunological techniques.

    Homepage: www.medizin5.uk-erlangen.de/en/research-teaching

 

Research Area 3: Targeted immunomodulatory therapy

  • H: Harnessing immune responses in hematological malignancies by redox remodeling

    Principle investigators: PD Dr. Dimitrios Mougiakakos and Prof. Dr. Andreas Mackensen, Department of Hematology and Oncology, University Hospital, Friedrich-Alexander-University, Erlangen, Germany

    Brief description: Emerging evidence suggest that tumor-associated oxidative stress weakens the patients’ immune system and thereby contributes to tumor immune escape and attenuates the efficacy of immune based therapies. In this PhD project we aim to (1) evaluate oxidative stress-induced immune alterations in patients with leukemia and to develop strategies for pharmacologically (2) antagonizing this metabolic condition and for (3) enhancing the resilience of immune cells towards it. The ultimate goal is to boost intrinsic anti-tumor immune responses and to increase the efficacy of immune based therapies. The methods utilized in this translational project will comprise a broad variety of cellular, immunological, and metabolic techniques.

    Homepage: www.medizin5.uk-erlangen.de/en/research-teaching

  • I: Combination of radiotherapy with Hsp90 inhibition to enhance the extent and the immunogenicity of tumor cell death for the treatment of sarcoma

    Principle investigators: Prof. Kirsten Lauber, Clinic for Radiotherapy and Radiation Oncology, Ludwig-Maximilians-Universität, Munich, Germany

    Brief description: The induction of immunogenic forms of cell death by specific radiotherapeutic regimes appears to be a promising approach for the stimulation of innate and adaptive anti-tumor immune responses. The aim of this PhD project is to explore, whether Hsp90 inhibition in combination with radiotherapy can enhance the extent as well as the immunogenicity of sarcoma cell death, and whether this can contribute to the stimulation of anti-sarcoma immune responses. To this end, various molecular, cell biological, and immunological methods will be employed, including in vivo experiments.

    Homepage: www.klinikum.uni-muenchen.de/Klinik-und-Poliklinik-fuer-Strahlentherapie-und-Radioonkologie/de/forschung/molek_onkologie/index.html

  • J: Card9 signaling in anti-tumor immunity

    Principle investigator: Prof. Jürgen Ruland, Institut für Klinische Chemie und Pathobiochemie, Klinikum rechts der Isar der Technischen Universität München

    Brief description: T cell activation is controlled by signals from antigen-presenting cells (APCs). APCs express multiple distinct pattern recognition receptors that can respond to specific innate immune stimuli and trigger unique signaling pathways that can prime T cell responses in a differential manner. The downstream adapter protein Card9 is absolutely critical for this process. Using in vitro and in vivo techniques, the PhD student will characterize the role of Card9 in the induction of T cell responses and tumor immunity. Another major aim of the project is to investigate the role of innate immune effectors on tumor growth and survival and their role in the tumor environment.
    Homepage: www.klinchem.med.tum.de

  • K: Targeting myeloid-derived suppressor cells (MDSC) in pancreatic cancer with ligands of RIG-I like helicases (RLH)

    Principle investigator: Prof. Max Schnurr, Division of Clinical Pharmacology, University Hospitals, Ludwig-Maximilians-Universität, Munich, Germany

    Brief description: Pancreatic cancer is characterized by an immunosuppressive network involving immature myeloid cells, so called MDSCs. Reprogramming MDSCs from an immunosuppressive (M2) towards an immunogenic (M1) phenotype is a novel therapeutic approach for breaking immunosuppression in tumors. The aim of this PhD project will be to assess the influence of immune stimulatory RNA species that activate the cytosolic helicase RIG-I on MDSC functional profiles, both tumor-promoting and -inhibitory. The methods will comprise a wide range of cellular and immunological methods and will include in vivo experiments in murine pancreatic carcinoma models.

    Homepage: www.klinikum.uni-muenchen.de/Abteilung-fuer-Klinische-Pharmakologie/de

250 PhD candidates Scholerships

logo-print

Working at TU/e

TU/e and its industrial partners are looking for 250 PhD candidates with a passion for research and innovation

Together with its partners in industry and research, TU/e (Eindhoven

University

of Technology) is looking for 250 extra PhD candidates in the coming year. The university is investing a total of more than € 23 million for this purpose, and is making available the required accommodation and facilities. Companies and fellow research institutes are investing a further € 30-40 million.Through this initiative, TU/e and its partners aim to strengthen the research partnerships in important areas such as energy, health, mobility, high-tech systems, data science and materials. These are fields in which numerous companies and organizations in the Brainport region are working on innovative solutions. TU/e and its partners aim in this way to reverse the decline in numbers of PhD candidates resulting from the pressure on government funding.

PhD candidates carry out scientific research at a university over a four-year period, after which they write their doctoral thesis. In those four years the researchers generate new scientific knowledge. TU/e announced at the beginning of 2013 that it was allocating € 13 million, and 66 PhD positions have been created with these funds. A further 10 million has now been added to this funding. The university is also providing accommodation and facilities. For each PhD position funded by TU/e, companies and fellow research institutes will finance an additional position. The total number of PhD positions will be around 250.

Focus on innovation and grand challenges

The PhD positions will become available in the following clusters:

Research clusters

Strategic area Energy Materials

also see Chemelot InSciTe 

Built Environment Biobased Building Blocks
Extreme Conditions & Materials Biomedical Devices
Future Fuels  
  Intelligent Lighting
Strategic area Health Infrastructure and Testbeds
Regenerative Engineering Interaction and Design
Personalized health technologies Optics and rendering
Perinatal Monitoring  
  Mechatronics
Strategic area Smart Mobility  
Cooperative & Autonomous driving Wireless Sensor Networks
EV Efficiency  
Traffic Management & Logistics Data Science

Interested in a PhD position?

These PhD positions will become available in phases in the coming year.

Read more

Scholarships-MSc in Math Engg

 

Scholarships worth 48,000 euros to attend a European joint MSc in Mathematical Engineering.

MathMods is a two-year joint Master of Science (MSc) programme (120 ECTS) between 5 European universities, which aims to provide students with a cross cultural education while they get acquainted with both theory and applications of mathematical modelling in engineering.

Several cholarships are offered by the European Commission to both non- European and European students. These scholarships amount to a maximum of EUR 48,000.00 to cover the two-year expenses and are granted to the most promising applicants.

CONSORTIUM

The MathMods Consortium is coordinated by the

– University of L’Aquila in Italy (UAQ)

and involves other four leading institutions in Europe:

– Autonomous University of Barcelona in Catalonia (UAB),

– Gdansk University of Technology in Poland (GUT),

– University of Hamburg in Germany (UHH),

– University of Nice – Sophia Antipolis in France (UNS).

STUDY PROGRAMME

The MathMods Master’s degree course consists of four semesters. Each semester totals 30 ECTS credits. The mobility scheme involves two different locations at least. The first year is common for all students: this will guarantee an equal knowledge platform for all of them. The second year is divided into five paths, which reflect the partners’ field of excellence.

– First semester: Theory at UAQ, Italy

– Second semester: Numerics at UHH, Germany

– Third+Fourth semester: Applications at UAB / UHH / UAQ / GUT / UNSA

LANGUAGE

The language of the whole course is exclusively English at each of the five universities. Students must also attend (and acquire the relating credits of) a course of basic Italian language (first semester) and German language (second semester). Students will also have the opportunity to attend local language courses during their second year (spent at one of the five partners).

Further Information

Application Deadline : 31 January 2014